13F-HR filed by Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 23 holding rows worth $851,901,577.
- Accession
- 0001855655-23-000003
- Filer
- CIK 1855655
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 23 entries on the cover page, a total value of $851,901,577 stated on the cover page (in dollars after the unit check, H1), rows summing to $851,901,577 with VALUE read as dollars as filed, 13F file number 028-21950. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INCYTE CORP COM | 45337C102 | Stock | 852,830 | $68,499,306 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 238,772 | $66,120,742 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,267,970 | $57,451,721 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 477,585 | $54,349,173 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,054,870 | $52,659,110 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,751,167 | $51,151,588 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,954,512 | $49,742,330 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 857,925 | $48,961,780 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 352,808 | $43,088,441 | dollars as filed | |
| VOR BIOPHARMA INC | 929033108 | COM | 6,442,825 | $42,844,786 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 148,892 | $41,405,376 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 286,288 | $36,790,871 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 1,233,280 | $36,505,088 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 89,556 | $33,926,499 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 604,544 | $33,129,011 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 882,101 | $27,327,489 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 106,210 | $20,870,265 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 599,599 | $20,512,282 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 2,317,634 | $17,034,610 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 890,105 | $16,288,922 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 515,274 | $15,818,912 | dollars as filed | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 2,434,816 | $12,904,525 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 75,000 | $4,518,750 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001855655-23-000003 | this filing | 2023-02-14 | acceptance time not in the bulk data set |